Advertisement

Related Videos

Amit Sanyal, MD: A Clinician’s Perspective

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Opportunities to Optimize Cancer Policies Panel Discussion

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

Advertisement

Advertisement




Oct
29
Today In Oncology
AI Shear Wave Elastography Model for Diagnosing Breast Cancer in BI-RADS 3 or 4 Masses
ESMO Publishes Guidance on Large Language Model Use for Oncology Practice
How the Proliferation of Fraudulent Scientific Papers Is Threatening the Integrity of Cancer Research
Revumenib Approved by FDA for NPM1 AML
Cutaneous Squamous Cell Carcinoma AI Model Rivals Dermatologists in Differentiation Assessment
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo